プラズミノゲン活性化剤阻害剤-1とそのコファクターであるビトロネクチンは,マウスの血管損傷後の動脈栓を安定させます
S Konstantinides1, K Schäfer, T Thinnes
1Department of Vascular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Circulation
|February 7, 2001
まとめ
プラズミノゲン活性化剤阻害剤-1 (PAI-1) とビトロネクチン (VN) は,動脈血栓症における早期の血栓分解と栓塞を予防します. PAI-1は局所的に合成され,VNはプラズマから生成されます.
科学分野:
- 心血管生物学 心血管生物学
- ヘモスタシスとトランボシス
- 分子医学は分子医学である.
背景:
- プラズミノゲン活性化剤阻害剤-1 (PAI-1) とビトロネクチン (VN) の動脈血栓症と血栓解離における役割は議論されている.
- 彼らのインビボの貢献を理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- 動脈血栓形成と安定性に対するPAI-1とVNの特定の貢献を調査する.
- 血管損傷の部位におけるPAI-1とVNの蓄積の起源を解明する.
主な方法:
- 野生型,PAI-1ノックアウト,VNノックアウトマウスの鉄塩化物による頸動脈損傷の誘導.
- 血栓閉塞の評価,閉塞までの時間,血栓の安定性,および開通率.
- PAI-1とVNの局所化と合成を決定するために,組織化学および遺伝子発現分析 (RT-PCR) を行う.
主要な成果:
- PAI-1欠乏症のマウスは,野生型と比較して,減少したおよび遅れた血栓閉塞を示した.
- VN欠乏したマウスは,血栓化に弱い不安定なトロンビを示し,より高い開通率をもたらしました.
- PAI-1発現は,血栓と血管壁で局所的に上調され,VNタンパク質は血から蓄積された.
結論:
- PAI-1とVNは,動脈損傷後の早期の血栓溶解と栓塞を予防するために重要です.
- PAI-1は局所合成を通じて,血栓の安定性に寄与する.
- 血栓の安定化におけるVNの役割は,血由来タンパク質によって媒介されるようです.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:05Introduction to Hemostasis
14.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.3K
01:22Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.0K
01:16Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482